All lobbying filings
S-3 Group
S-3 Group filed a Q3 report for Alkermes, Inc. on October 16, 2026, reporting $80,000 in lobbying income.
Lobbying for Alkermes, Inc. · Global biopharmaceutical company specializing in innovative treatments
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
5
-
JOHN SCOFIELDPreviously held: Comm Dir, House Approps, Press Sec., Rep LoBiondo
-
MARTIN DELGADOPreviously held: Staff Dir, House Ag Approps, Prof Staff, Milcon/VA Approps
-
OLIVIA KURTZPreviously held: Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle
-
ASHLEY DAVISPreviously held: Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President
-
CHANDA BETOURNEYPreviously held: Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy
Government bodies contacted
2
Lobbying activity
1
Issues related to legislation and policies that support treatment for alcohol and opioid dependency at SAMSHA, VA and DOJ